MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Vertex Pharmaceuticals Incorporated Company Profile (NASDAQ:VRTX)

Consensus Ratings for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) (?)
Ratings Breakdown: 7 Hold Rating(s), 16 Buy Rating(s)
Consensus Rating:Buy (Score: 2.70)
Consensus Price Target: $143.36 (11.74% upside)

Current Analysts' Coverage Summary for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Show:
DateFirmActionRatingPrice TargetActions
7/24/2015HC WainwrightReiterated RatingNeutral$85.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/7/2015William BlairBoost Price TargetOutperform$138.00 -> $158.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/7/2015Morgan StanleyLower Price Target$120.00 -> $119.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/7/2015JMP SecuritiesLower Price TargetMarket Outperform$152.00 -> $145.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/7/2015BTIG ResearchLower Price TargetBuy$200.00 -> $180.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/6/2015Piper JaffrayReiterated RatingOverweight$146.00 -> $161.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/6/2015Leerink SwannReiterated RatingOutperform$150.00 -> $158.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/6/2015Bank of AmericaBoost Price TargetNeutral$130.00 -> $133.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/6/2015Robert W. BairdBoost Price TargetBuy$131.00 -> $160.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/3/2015Goldman SachsReiterated RatingBuy$142.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/23/2015RBC CapitalBoost Price TargetOutperform$130.00 -> $145.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/5/2015Canaccord GenuityReiterated RatingBuy$150.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/14/2015JPMorgan Chase & Co.Reiterated RatingOverweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/13/2015Needham & Company LLCReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/30/2015Citigroup Inc.Boost Price TargetBuy$141.00 -> $156.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2015OppenheimerInitiated CoverageMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/23/2015Deutsche BankSet Price TargetBuy$155.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/29/2015Credit SuisseBoost Price TargetBuy$129.00 -> $155.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/29/2015Maxim GroupDowngradeBuy -> Hold$148.00 -> $121.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/9/2015Janney Montgomery ScottInitiated CoverageNeutral$126.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/6/2015BarclaysInitiated CoverageEqual Weight$120.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/5/2014CRT CapitalInitiated CoverageBuy$175.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/13/2014Wells Fargo & Co.UpgradeNeutral -> Outperform$129.00 -> $125.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/2/2014GuggenheimInitiated CoverageBuy$147.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/25/2014Sanford C. BernsteinBoost Price Target$65.00 -> $107.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/21/2014Ned Davis ResearchUpgradeSell -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/30/2013Summer StreetDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/29/2013Cowen and CompanyLower Price TargetNeutral$87.94 -> $80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/29/2013 forward)